CANCER PROGRAM
ANNUAL REPORT
2015
Bay Medical Center Sacred Heart Health System
Cancer Program Report 2015
Cancer Program Report 2015
B AY M E D I C A L C E N T E R S A C R E D H E A R T H E A LT H S Y S T E M
2015 Community Outreach
Throughout the year, Bay Medical offered a range of cancer community
programs and educational opportunities.
These activities provided cancer
prevention and early detection activities through venues such as seminar /
screenings,
brochures,
magazines,
mailings,
e-mails
and
public
broadcastings. Local physicians and other members of the medical field
collaborated in these programs.
Some of the 2015 events included:
Relay for Life
Skin Cancer Screening
Mammogram Awareness Campaign
Making Strides against Breast Cancer
Prostate Cancer Seminar
Look Good Feel Better
-Classes offered to the community to enhance patients’ appearance with a
cosmetologist coordinated by the American Cancer Society
Page 1
Cancer Program Report 2015
Making Strides against
Breast Cancer
Pink Gloves Campaign
Page 2
Cancer Program Report 2015
Cancer Registry
The Bay Medical Cancer Program has been accredited by the American
College of Surgeons Commission on Cancer (CoC) since 1997 and has
maintained accreditation since that time. The CoC sets program standards
and reviews facility compliance of those participating in their Accreditation
Program. Committed to quality care and improvements in cancer care at Bay
Medical, the multidisciplinary Cancer Committee leads and monitors the
program activity.
The Cancer Registry plays an essential role in the Comprehensive Community
Cancer Program at Bay Medical, collecting information on cancer incidence,
types of cancers, stage of disease, treatment, and outcomes, while adhering
to all Florida statutes and patient information guidelines, as well as federal
HIPAA laws. The data from the registry is submitted to the Florida Cancer
Data System as well as to the National Cancer Database in accordance with
guidelines. Reliable data is essential in the evaluation of cancer prevention
and treatment programs, as well as in monitoring quality care. This activity
provides information on cancer incidence, assists in directing the local and
statewide cancer prevention and control activities, as well as guiding local
community education, prevention and early-detection programs.
The Registry also participates in cancer program quality improvement
measures, outcomes analyses, and assists in monitoring compliance with
evidence based clinical practice guidelines. The Registry staff coordinates and
facilitates the Cancer Conferences, and collaborates with medical staff in
quality improvement studies and measures.
Cancer Registry Data
Summary of 2014 Statistics
The top five sites that were most frequently diagnosed and / or treated at Bay
Medical in 2014 were Lung, Colorectal, Breast, Non-Hodgkin Lymphoma, and
Kidney and Renal Pelvis. The most frequent stage at diagnosis for each of
these sites was as follows: Lung - Stage IV; Colorectal - Stage III; Breast Stage I; Non-Hodgkin Lymphoma - Stage III; and, Kidney and Renal Pelvis Stage I. The following data and graphs reflect the distribution of 2014
analytic1 primary sites.
1 Cases
diagnosed and/ or received all or part of first course treatment at Bay Medical
Page 3
Cancer Program Report 2015
2014 ANALYTIC CASES
TOTAL
MALE
FEMALE
5
4
1
DIGESTIVE SYSTEM
111
60
51
RESPIRATORY SYSTEM
143
77
66
SOFT TISSUE
3
2
1
SKIN, EXCLUDING BASAL & SQUAMOUS
14
12
2
BREAST
66
0
66
FEMALE GENITAL SYSTEM
12
0
12
MALE GENITAL SYSTEM
11
11
0
URINARY SYSTEM
39
32
7
BRAIN & OTHER NERVOUS SYSTEM
38
23
15
ENDOCRINE SYSTEM
20
5
15
LYMPHOMA
24
15
9
MYELOMA
7
5
2
LEUKEMIA
13
9
4
MESOTHELIOMA
3
3
0
ORAL CAVITY & PHARYNX
Page 4
Cancer Program Report 2015
Cancer Incidence – 2014 Cases
The frequency of the 2014 top analytic cases is reflected below. Lung cancer
was the leading site for males, and breast cancer was the leading site for
females followed by lung cancer.
2014 Cancer Cases
Percentages by Site
Lung 26%
Colorectal 12%
Breast 12%
Non-Hodgkin Lymphoma 4%
Kidney & Renal Pelvis 4%
Other Cancers 42%
Page 5
Cancer Program Report 2015
Cancer Case Comparison
The percentages below reflect the comparison of Bay Medical 2014 cases to
state and national estimates from the American Cancer Society Cancer Facts &
Figures 2015. The data shows a higher occurrence of lung cancer at Bay Medical
when compared to state and national data. In response, Bay Medical initiated a
lung cancer screening program in 2015.
30%
25%
26%
20%
15%
15%
14% 14%
13%
12%
12%
10%
8% 8%
5%
5%
4%
4%
4%
4%
NA
0%
Lung
Colorectal
Breast
BMC
FL
Non-Hodgkin
Lymphoma
Kidney & Renal
Pelvis
USA
Page 6
Cancer Program Report 2015
2014 Gender Distribution
Analytic Cases
Female, 48.3%
Male, 51.7%
Top Five Primary Sites by Gender
2014 Analytic Cases
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
Lung
Colorectal
Breast
NHL
Male
53.6%
59.7%
0.0%
65.2%
Kidney &
Renal Pelvis
70.0%
Female
46.4%
40.3%
100.0%
34.8%
30.0%
Male
Female
Page 7
Cancer Program Report 2015
2015 Screening Program
The most commonly diagnosed cancer in the United States is skin cancer.
The actual numbers of non-melanoma skin cancers (basal cell and squamous
cell skin cancer), which are the most common types, are difficult to quantify.
This is because basal and squamous cell skin cancers are not reported
cancers. The most recent study in 2006, estimated that 3.5 million cases
were diagnosed among 2.2 million people. In 2015, it is estimated that in the
United States over 3 million cases of skin cancer will be diagnosed. It is
estimated that there will be 73,870 new cases of melanoma diagnosed in
2015, with 5,480 of those diagnosed in Florida. Melanoma comprises less
than 2% of all skin cancer cases, and is highly curable when detected in its
earliest stages, but it is more likely to spread to other parts of the body than
basal or squamous cell skin cancer. 1
The most recent age-adjusted incidence report for melanoma in Bay County
(2010-2012) reflects an annual incidence rate of 20.9 cases per 100,000
compared to 17.5 for Florida.2
The most recent five year age-adjusted
incidence rate for Florida (2008-2012), reflects a rate of 19.8 cases per
100,000 compared to 19.9 for the US.3 In 2014, there were 13 Bay Medical
analytic cases of melanoma. Three of these were diagnosed at Stage 0, nine
were Stage I and II, and one was Stage IV. From 2010 through 2014, there
were 52 analytic cases of melanoma at Bay Medical. Of Those cases, there
were four Stage 0, twenty-four Stage I, eleven Stage II, two Stage III, eight
Stage IV, and three were unable to be staged.
Annual skin cancer screening (visual inspection of skin by a medical
professional) can help identify melanoma and other skin cancers. Bay Medical
Center Sacred Heart Health System, in collaboration with local dermatologist
Dr. Michael Stickler and his staff, offered a free skin cancer screening on July
17th, 2015. There were a total of 18 who participated in this event.
Attendees had the opportunity to learn about skin cancer prevention and
risks and be screened for possible skin cancer by Dr. Stickler. Each
participant was offered the option of a full or partial screen. Of those
examined, more than half (56%) were identified as having potential positive
results. Participants were able to interact with the physician, ask questions
and discuss concerns. Recommendations and provisions for follow-up were
provided. All activities were in accordance with evidence-based national
guidelines.
1
American Cancer Society, Cancer Facts and Figures 2015
Florida Department of Health
3 NCI State Cancer Profiles
2
Page 8
Cancer Program Report 2015
Accountability and Quality Improvement Measures
The performance rates reflect patients with breast, colon, gastric, lung, and
rectal cancer with documentation of treatment according to standard of care.
Goals are established by the American College of Surgeons Commission on
Cancer. Note: Patients receive outpatient treatment elsewhere and may not
have complete treatment information.
Breast
Standard: Radiation is administered within 1 year (365 days) of diagnosis for women
under age 70 receiving breast conservation surgery for breast cancer.
Goal: 90%
Standard: Tamoxifen or third generation aromatase inhibitor is recommended or
administered within 1 year (365 days) of diagnosis for women with AJCC T1c, or
Stage IB-III hormone receptor positive breast cancer.
Goal: 90%
Standard: Image or palpation-guided needle biopsy to the primary site is performed
to establish diagnosis of breast cancer.
Goal: 80%
Standard: Radiation therapy is recommended or administered following any
mastectomy within 1 year (365 days) of diagnosis of breast cancer for women with >
= 4 positive regional lymph nodes.
Goal: 90%
Colon
Standard: At least 12 regional lymph nodes are removed and pathologically
examined for resected colon cancer.
Goal 85%
Gastric
Standard: At least 15 regional lymph nodes are removed and pathologically
examined for resected gastric cancer.
Goal: 80%
Lung
Standard: Systemic chemo is administered within 4 months to day pre-op or day of
surgery to 6 months postop, or it is recommended for surgically resected cases with
pathologic lymph node-positive (pN1) and (pN2) NSCLC.
Goal: 85%
Rectum
Standard: Preoperative chemo and radiation are administered for clinical AJCC T3N0,
T4N0, or stage III; or postoperative chemo and radiation are administered within
180 days of diagnosis for clinical AJCC T1-2N0 with pathologic AJCC T3N0, T4N0, or
Stage III; or treatment is recommended; for patients under the age of 80 receiving
resection for rectal cancer.
Goal: 85%
Performance: All measures with applicable cases were compliant, being either
above goal percentage or with an upper limit of the 95% confidence interval above
the set benchmark.
Page 9
Cancer Program Report 2015
615 N. Bonita Avenue
Panama City, FL 32401
Page 10